Disease-Vaccine-Landing-Page/Influenza/vaccine-history

Despite the ever-growing number of influenza vaccines available in the U.S. market, the effectiveness of influenza vaccines has not improved very much over the years. In 2003-2004, the CDC increased...

As the influenza vaccine market expanded, so did recommendations for use by the CDC’s Advisory Committee on Immunization Practices (ACIP).In 1984, the CDC recommended annual flu shots for high risk...

In addition to an increase in the types of available influenza vaccines, manufacturers have also added new delivery methods. In 2012, the first intradermal influenza vaccine (administered between skin layers...

In 2015, the FDA approved FLUAD, a trivalent influenza vaccine containing MF 59, a squalene oil adjuvant that hyper-stimulates the immune system to produce more antibodies, for use in adults...

On June 26, 2014, the CDC recommended giving FluMist to healthy children between 2 and 8 years of age instead of inactivated injectable influenza vaccines but, 2 years later, in...

The influenza vaccine market has grown considerably since 2009 with the introduction of several new types of influenza vaccines along with new delivery methods, including vaccines that use insect and...

On April 26, 2009, public health officials declared a national public health emergency after the discovery of a new Influenza A (H1N1) strain was first identified in Mexico and then...

The first live attenuated influenza vaccine (LAIV), FluMist, was approved by the FDA in 2003. A trivalent vaccine administered as a nasal spray, FluMist was approved for use in healthy...

Despite this setback, seasonal flu vaccine production continued and, in 1978, the first trivalent influenza vaccine was licensed for use in the U.S. after scientists identified two different influenza A...

In early 1976, two cases of H1N1 “swine flu” were confirmed in the U.S. and public health officials working with the pharmaceutical industry made the decision to start manufacturing a...